IP Library Granted Patent US 10,260,056
Granted Patent B2
US 10,260,056 · App. 15/894,252 · Granted Apr 16, 2019

Cleavage of fucose in N-glycans

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,260,056
App. No.
15/894,252
Granted
Apr 16, 2019
Kind
B2
Abstract

Provided herein is an α-fucosidase that can cleave a conjugate comprising an N-glycan and a label where the label is added by amine reactive chemistry. The α-fucosidase also has an accelerated reaction time using Schiff base labeled N-glycans compared with bovine kidney fucosidase. A reaction mix, enzyme mix and kit comprising the α-fucosidase are provided, as well as a method for analyzing glycoproteins. The α-fucosidase finds particular use in analyzing the N-glycans of therapeutic glycoproteins.

Claims (42)

1. A reaction mix comprising:

(a) an α-L-fucosidase comprising an amino acid sequence that is identical to amino acids 23-359 of the sequence of SEQ ID NO:1; and

(b) a conjugate comprising an N-glycan and a label that are joined by an carbamide bond.

2. The reaction mix of claim 1 , wherein the label comprises a fluorophore and/or a charge tag.

3. The reaction mix of claim 1 , wherein the N-glycan of the conjugate comprises a core fucose.

4. The reaction mix of claim 1 , wherein the N-glycan is linked to the label via the reducing end of the N-glycan.

5. The reaction mix of claim 1 , wherein the N-glycan is from a therapeutic glycoprotein.

6. The reaction mix of claim 1 , wherein the reaction mix further comprises:

(c) one or more exoglycosidases selected from the group consisting of:

α2-3 neuraminidase S;

α2-3,6,8,9 neuraminidase A;

α1-3,4,6 galactosidase;

β1-4 galactosidase;

β-N-acetylglucosaminidase S; and

α1-2,3,6 mannosidase.

7. The reaction mix of claim 1 , wherein the reaction mix has a pH in the range of pH 3.0 to pH 5.5.

8. An enzyme mix comprising:

(a) an α-fucosidase comprising an amino acid sequence that is identical to amino acids 23-359 of the sequence of SEQ ID NO:1; and

(b) one or more exoglycosidases that are not encoded by the genome of Omnitrophica , selected from the group consisting of:

α2-3 neuraminidase S;

α2-3,6,8,9 neuraminidase A;

α1-3,4,6 galactosidase;

β1-4 galactosidase;

β-N-acetylglucosaminidase S; and

α1-2,3,6 mannosidase.

9. The enzyme mix according to claim 8 , wherein none of the one or more exoglycosidases in the enzyme mix is glycosylated.

10. The enzyme mix of claim 8 , wherein the enzyme mix comprises two or more of the exoglycosidases.

11. The enzyme mix of claim 8 , wherein the enzyme mix comprises three or more of the exoglycosidases.

12. The enzyme mix of claim 8 , wherein the enzyme mix comprises α2-3 neuraminidase S, α2-3,6,8,9 neuraminidase A, α1-3,4,6 galactosidase, β1-4 galactosidase and β-N-acetylglucosaminidase S.

13. A kit, comprising:

a. an α-fucosidase comprising an amino acid sequence that is identical to amino acids 23-269 of the sequence of SEQ ID NO:1; and

b. a label comprising a reactive carbamate.

14. The kit of claim 13 , wherein the kit further comprises peptide:N-glycosidase F (PNGase F).

15. The kit of claim 13 , further comprising one or more exoglycosidases selected from the group consisting of:

α2-3 neuraminidase S;

α2-3,6,8,9 neuraminidase A;

α1-3,4,6 galactosidase;

β1-4 galactosidase;

β-N-acetylglucosaminidase S; and

α1-2,3,6 mannosidase.

16. The kit of claim 15 , wherein at least one of the one or more exoglycosidases is combined with the α-fucosidase in a reaction mixture.

17. The kit of claim 13 , wherein the label comprises a fluorophore and/or a charge tag.

Assignments (2)
NOTICE OF GRANT OF SECURITY INTEREST IN PATENTS Recorded Sep 27, 2023
From: NEW ENGLAND BIOLABS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065044/0729 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 12, 2018
From: TARON, CHRISTOPHER H.; VAINAUSKAS, SAULIUS; SHI, XIAOFENG
To: NEW ENGLAND BIOLABS, INC.
Reel/Frame 044902/0144 →